Market closedNon-fractional
Enzo Biochem/ENZ
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Enzo Biochem
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Ticker
ENZ
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Providers and Services
Headquarters
Farmingdale, United States
Employees
185
Website
www.enzo.com
Enzo Biochem Metrics
BasicAdvanced
$55M
Market cap
1.21
P/E ratio
$0.89
EPS
0.78
Beta
-
Dividend rate
Price and volume
Market cap
$55M
Beta
0.78
Financial strength
Current ratio
3.496
Quick ratio
2.82
Long term debt to equity
4.02
Total debt to equity
10.514
Interest coverage (TTM)
-15.07%
Management effectiveness
Return on assets (TTM)
-12.77%
Return on equity (TTM)
-39.90%
Valuation
Price to earnings (TTM)
1.207
Price to revenue (TTM)
1.618
Price to book
0.8
Price to tangible book (TTM)
0.8
Price to free cash flow (TTM)
-1.249
Growth
Revenue change (TTM)
-204.05%
Earnings per share change (TTM)
-194.91%
3-year revenue growth
-33.32%
3-year earnings per share growth
221.37%
Enzo Biochem Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$8.5M
8.97%
Net income
-$3M
-54.55%
Profit margin
-35.29%
-58.29%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Enzo Biochem stock?
Enzo Biochem (ENZ) has a market cap of $55M as of July 06, 2024.
What is the P/E ratio for Enzo Biochem stock?
The price to earnings (P/E) ratio for Enzo Biochem (ENZ) stock is 1.21 as of July 06, 2024.
Does Enzo Biochem stock pay dividends?
No, Enzo Biochem (ENZ) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Enzo Biochem dividend payment date?
Enzo Biochem (ENZ) stock does not pay dividends to its shareholders.
What is the beta indicator for Enzo Biochem?
Enzo Biochem (ENZ) has a beta rating of 0.78. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Enzo Biochem stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.